IVF Cost Structure 1) Basic medical: pre-op tests (hormones, chromosomes, infectious disease) ~3,000–8,000; stimulation drugs (domestic ~5,000–15,000; imported ~20,000–30,000); retrieval & embryo culture ~20,000–40,000. 2) Technology upgrades: ICSI +5,000–10,000; embryo freezing first year ~5,000 then ~2,000/yr; PGT +30,000–80,000. 3) Potential extras: repeat transfers may double cost; OHSS treatment adds thousands. Ranges: IVF 30,000–50,000; ICSI 40,000–60,000; PGT 80,000–150,000.

Why So High? Four Reasons 1) Technology threshold and equipment (incubators, micromanipulators, high-standard labs costing millions). 2) Professional team and long monitoring (multidisciplinary; labor ~30% of cost). 3) Drug dependence and import monopoly (e.g., Gonal-f; domestic 30%–50% cheaper but variable). 4) Success rate and repeat cycles—reported domestic average ~50% (clinic-reported); advanced-age or complex cases may need 2–3 cycles, totaling 100,000–200,000.

How to Cope 1) Plan scientifically—treat before 35 for higher reported success; assess via AMH/hysteroscopy to avoid wasted spending. 2) Choose technology appropriately—no need for third generation without genetic history or severe male factor; use domestic drugs to save ~30%. 3) Use policy and insurance—from 2023, Guangxi, Beijing, etc. cover some items (up to 50%); some insurers offer IVF insurance. 4) Cross-border value—Laos, Thailand third-generation IVF ~30%–50% cheaper than the West (about 80,000–120,000) with lawful genetic screening, suiting budget-limited, genetically at-risk families.

Outlook Despite the challenge, the field is becoming more accessible: domestic substitution (e.g., Livzon) may lower costs; national insurance expansion is projected to reach 60%+ coverage by 2030; charities (e.g., China Population Welfare Foundation) offer 50,000–100,000 yuan aid. With planning, policy use, and technology, ordinary families can realize their fertility goals. (More info: QR code or 181-0136-5219.)